Evidence map›Paper›PMID 40938461›Full record

ArticleArchives of osteoporosis2025

Temporal trends in acute care costs of hip fracture treatment from 2011 to 2021 in Japan.

Masaki Hatano, Hideo Yasunaga, Hisatoshi Ishikura, Takeyuki Tanaka, Shotaro Aso, Sakae Tanaka

Abstract read
In one paragraph

Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Impact of a national reimbursement add-on policy on refracture risk and secondary fracture prevention after hip fracture in Japan: a population-based interrupted time series analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masaki HatanoDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo ku, Tokyo, 113-0033, Japan. h-masaki@g.ecc.u-tokyo.ac.jp.
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo ku, Tokyo, 113-0033, Japan.
Hisatoshi IshikuraDepartment of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.
Takeyuki TanakaDepartment of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.
Shotaro AsoDepartment of Health Services Research, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.
Sakae TanakaDepartment of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.

Funding

Ministry of Health, Labour and Welfare 22AA2003Ministry of Health, Labour and Welfare 23AA2003
6 · The paper itself

Abstract

We investigated annual trends in acute care costs for hip fracture treatment in Japan from 2011 to 2021. While gross medical costs and costs per hospitalization initially declined, both increased after 2013 and 2014, respectively. In contrast, daily medical costs per person rose steadily throughout the study period. PURPOSE: Hip fractures impose a substantial financial burden on healthcare systems, primarily due to acute-care hospitalization costs. Despite efforts over the past decade to improve hospital efficiency, trends in acute care costs for hip fracture treatment remain unclear. This study aimed to evaluate annual trends in these costs in Japan.

methodsWe conducted a nationwide retrospective cohort study using the Diagnosis Procedure Combination database in Japan. Patients aged ≥ 60 years who underwent hip fracture surgery between 2011 and 2021 were included. Primary outcomes were gross medical costs, costs per hospitalization, and daily medical costs per person. Secondary outcomes were length of hospital stay and waiting times for surgery.

resultsA total of 839,179 hip fracture cases were identified. Gross medical costs decreased from $890 million in 2011 to $830 million in 2013 but increased to $989 million in 2021. Medical costs per hospitalization declined from $11,587 in 2011 to $11,337 in 2014 and rose to $12,019 in 2021. In contrast, daily medical costs per person increased steadily from $378 to $442 over the study period. Both the mean hospital stay (37.1 to 33.1 days) and waiting times for surgery (3.5 to 3.0 days) decreased from 2011 to 2021.

conclusionAlthough hospital efficiency improved, initial decreases in gross costs and costs per hospitalization were followed by gradual increases after 2013 and 2014, respectively. Meanwhile, daily medical costs per person consistently increased, underscoring the sustained economic burden of acute hip fracture care.

Indexed as

Health Care CostsHip FracturesHospitalizationAgedAged, 80 and overFemaleHumansJapanLength of StayMaleMiddle AgedRetrospective StudiesCostEconomic burdenHip fractureLength of stay

Identifiers

PMID40938461
PMCPMC12432063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.